NasdaqCM - Nasdaq Real Time Price USD
Alpha Tau Medical Ltd. (DRTSW)
0.2300
+0.0112
+(5.12%)
At close: April 23 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Uzi Sofer | CEO & Chairman | 649k | -- | 1970 |
| Mr. Raphi Levy | Chief Financial Officer | 420k | -- | 1985 |
| Mr. Amnon Gat | Chief Operations Officer | 345k | -- | 1975 |
| Mr. Ronen Segal | Chief Technology Officer | 269k | -- | 1973 |
| Dr. Robert B. Den M.D. | Chief Medical Officer & Member of Scientific Advisory Board | 394k | -- | 1979 |
| Prof. Yona Keisari | Chief Scientific Officer & Member of Scientific Advisory board | -- | -- | 1947 |
| Ms. Rebecca Becker | Vice President of legal | -- | -- | -- |
| Mr. Peter M. Melnyk | Chief Commercial Officer | 376k | -- | 1962 |
| Prof. Itzhak Kelson | Chief Physics Officer & Member of Scientific Advisory Board | -- | -- | 1940 |
| Ms. Yael Zeiger | Corporate Controller | -- | -- | 1983 |
Alpha Tau Medical Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 125
Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.
Corporate Governance
Alpha Tau Medical Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
ESLAW Estrella Immunopharma, Inc.
0.0885
+5.11%
CELUW Celularity Inc.
0.0382
+6.11%
CINGW Cingulate Inc.
0.0370
+11.78%
TVGNW Tevogen Bio Holdings Inc.
0.0478
+11.68%
TCBPY TC Biopharm (Holdings) Plc
0.4500
+45.16%
QLGN Qualigen Therapeutics, Inc.
3.8500
-0.26%
ABUS Arbutus Biopharma Corporation
3.2400
+1.57%
TLSA Tiziana Life Sciences Ltd
1.3100
+12.93%
BBIO BridgeBio Pharma, Inc.
35.23
+3.07%
MAIA MAIA Biotechnology, Inc.
2.0500
+9.63%